by Nathaniel Harding | Sep 23, 2022 | Newsletters
Bottom Line Up Front (BLUF) In this month’s Doubleshot Newsletter, you will find: MoatBio Announces Successful Clinical Trials of Intranasal COVID-19 Vaccine Builder Highlight: OKC MED Week LP Highlight: Presbyterian Health Foundation Cortado’s Due Diligence Process...
by Nathaniel Harding | Sep 20, 2022 | Blog, Media
OKLAHOMA CITY (KFOR) – An Oklahoma company hopes to get you the benefits of a COVID-19 vaccine – without the needles! Moat Biotechnology is working on an intranasal vaccine that could prove very effective in fighting the virus. Read Full Article on...
by Nathaniel Harding | Sep 20, 2022 | Media
Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine OKLAHOMA CITY (Sept. 20, 2022) — Moat Biotechnology Corporation (MoatBio), a new...
by Nathaniel Harding | Sep 16, 2022 | Blog
Not sure what to expect during the due diligence process? Here’s our step-by-step guide to due diligence from initial contact to investment. Cortado Ventures’ Due Diligence Process All entrepreneurs who raise venture capital funds have to go through due diligence, yet...
by Nathaniel Harding | Sep 14, 2022 | Blog
“It is time to move STEM forward in Oklahoma… the revolution of medicine is happening now.” And Deborah Moorad, one of Oklahoma City’s most-recent biotech success stories, is right in the center of that revolution, and she has the voice to speak into what Oklahoma’s...
